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Multiminicore disease (MmD) is an autosomal recessive congenital myopathy characterized by the presence of
multiple, short core lesions (known as “minicores”) in most muscle fibers. MmD is a clinically heterogeneous
condition, in which four subgroups have been distinguished. Homozygous RYR1 mutations have been recently
identified in the moderate form of MmD with hand involvement. The genes responsible for the three other forms
(including the most prevalent phenotype, termed the “classical” phenotype) remained, so far, unknown. To further
characterize the genetic basis of MmD, we analyzed a series of 62 patients through a combined positional/candidate-
gene approach. On the basis of clinical and morphological data, we suspected a relationship between classical MmD
and the selenoprotein N gene (SEPN1), which is located on chromosome 1p36 (RSMD1 locus) and is responsible for
the congenital muscular dystrophy with rigid spine syndrome (RSMD). A genomewide screening, followed by the
analysis of 1p36 microsatellite markers in 27 informative families with MmD, demonstrated linkage to RSMD1
in eight families. All showed an axial myopathy with scoliosis and respiratory failure, consistent with the most
severe end of the classical MmD spectrum; spinal rigidity was evident in some, but not all, patients. We excluded
linkage to RSMD1 in 19 families with MmD, including 9 with classical MmD. Screening of SEPN1 in the 8 families
that showed linkage and in 14 patients with classical sporadic disease disclosed 9 mutations affecting 17 patients
(12 families); 6 were novel mutations, and 3 had been described in patients with RSMD. Analysis of three deltoid
biopsy specimens from patients with typical RSMD revealed a wide myopathological variability, ranging from a
dystrophic to a congenital myopathy pattern. A variable proportion of minicores was found in all the samples.
The present study represents the first identification of a gene responsible for classical MmD, demonstrates its genetic
heterogeneity, and reassesses the nosological boundaries between MmD and RSMD.
Introduction
MmD is an early-onset, autosomal recessive congen-
ital myopathy characterized by the presence of multiple,
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poorly circumscribed, short areas of sarcomere disor-
ganization and mitochondria depletion (areas that are
termed “minicores”) in most muscle fibers (Engel et al.
1971). Typically, no dystrophic signs, such as muscle
fiber necrosis or regeneration or significant endomysial
fibrosis, are present in MmD. The most common clinical
presentations are neonatal hypotonia, delayed motor de-
velopment, and generalized muscle weakness and amy-
otrophy, which may progress slowly or remain stable.
Nevertheless, MmD is a clinically heterogeneous con-
dition in which four subgroups have been distinguished
(Ferreiro et al. 2000; Jungbluth et al. 2000; Ferreiro and
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Fardeau 2002). The phenotype of the classical form,
which is the most prevalent, is characterized by the pre-
dominance of axial muscle weakness that leads, in two-
thirds of patients, to the development of severe, life-
threatening respiratory insufficiency and scoliosis. The
moderate form of MmD with hand involvement consists
of generalized muscle weakness that affects predomi-
nantly the pelvic girdle, and includes hand weakness,
amyotrophy, and hyperlaxity; scoliosis and respiratory
involvement are mild or absent (Ferreiro et al. 2002).
Of the two other forms of the disease, one is character-
ized by a clinical picture similar to that of the classical
form but includes ophthalmoplegia (MIM 255320)
(Jungbluth et al. 2000), and the second is characterized
by antenatal onset with arthrogryposis (Ferreiro et al.
2000). Because of this wide clinical spectrum, genetic
heterogeneity of MmD was long suspected, and it has
been recently proved by the identification of homozy-
gous mutations of the skeletal muscle ryanodine receptor
gene (RYR1 [MIM 180901]), which are responsible for
the moderate form with hand involvement (Ferreiro et
al. 2002). The genetic basis of the three remaining MmD
forms was, so far, unknown.
We describe here the identification, in 17 patients
with classical MmD, of nine different mutations in
the selenoprotein N gene (SEPN1 [MIM 606210]), the
gene recently recognized as responsible for congenital
muscular dystrophy with rigid spine (RSMD [MIM
#602771]) (Moghadaszadeh et al. 2001). Interestingly,
three of these mutations are identical to those described
elsewhere in patients with RSMD; six of them, including
a mutation of the first base in the translation start codon
ATG (1ArG), are novel changes. Linkage of MmD to
the RSMD1 locus was excluded in 19 informative fam-
ilies with MmD, including 9 with the classical form of
the disease; this observation demonstrates the existence
of genetic heterogeneity, even within the classical group.
The present report is the first description of a gene re-
sponsible for the classical MmD phenotype, and it in-
dicates the need to reassess the nosological boundaries
between MmD and RSMD, which, until now, have been
considered two distinct entities.
Subjects and Methods
Patients
Sixty-two patients with MmD, who belonged to 41
families, were included in this study; 27 families were
informative, and, of these, 14 were thought to include
consanguineous parents (consanguinity documented in
12 and possible in 2), and 13 included 2 affected chil-
dren. This informative group comprised 48 patients with
an initial diagnosis of classical (16 families), ophthal-
moplegia (2 families), arthrogryposis-kyphosis (2 fami-
lies), or atypical (7 families) MmD. Each of the remain-
ing 14 families included a single patient with classical
MmD. All parents appeared to be normal during clinical
examination. Families F2, F6, F10, and F11 have been
described elsewhere (as families F6, F13, F5, and F2,
respectively, in the publication by Ferreiro et al. [2000]).
In all patients, the diagnosis of MmD was established
after analysis, by light and electron microscopy, of a mus-
cle biopsy specimen from at least one patient per family.
Our selection criteria have been described in detail else-
where (Ferreiro et al. 2002). They included a clinical
picture highly suggestive of a congenital myopathy, ev-
idence of autosomal recessive transmission, and the pres-
ence of multiple minicores in both type 1 and type 2
muscle fibers as the main morphological abnormality.
The presence of any morphological sign of muscular
dystrophy, such as a necrosis-regeneration pattern or sig-
nificant endomysial fibrosis, was an exclusionary crite-
rion. The typical myopathological features of MmD are
shown in figure 1.
Clinical evaluation, muscle biopsies, and drawing of
blood samples were performed after written informed
consent was obtained, in accordance with the protocol
approved by the local ethics committees.
Morphological Methods
Specimens obtained during open muscle biopsies were
immediately frozen or fixed and were processed for light
microscopy and ultrastructural studies as described else-
where (Ferreiro et al. 2000).
Genotyping
Genomic DNA was extracted from blood samples or
lymphoblastoid cell lines, using standard procedures. A
whole-genome screening was performed in 13 informative
families, using a 400-microsatellite marker set (Applied
Biosystems) with an average spacing of 10 cM. These
fluorescently labeled markers were coamplified (an av-
erage of four markers per reaction) in a total reaction
volume of 10 ml, using TaqGold polymerase (0.4 U) (Per-
kin-Elmer) and the GeneAmp 9700 PCR system (Applied
Biosystems). After automated purification, the PCR prod-
ucts were separated using a MegaBace 1000 sequencer
(Amersham Biosciences), and the allele values were de-
fined using MegaBace Collection software and Genetic
Profiler software, v. 1.1 (Amersham Biosciences).
Additional polymorphic markers were used for fine
mapping of potential loci. Markers D1S3766, D1S3767,
D1S2885, D1S3768, and D1S3769 (Moghadaszadeh et
al. 1998) were amplified using forward primers labeled
with 6-FAM, HEX, or NED fluorochromes and were
placed on gels in an ABI 377 automated sequencer (Ap-
plied Biosystems). Results were analyzed using GENO-
TYPER software, v. 2.0 (Applied Biosystems).
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Figure 1 Histochemical and ultrastructural features of MmD.
a–d, Serial transverse cryostat sections. a and b, Patient 16 at 5 years
of age, left deltoid, stained with hematoxylin-eosin (HE) (a) and my-
osin adenosine triphosphatase, pH 9.4 (b). Note variability of fiber
size and predominance of type 1 (lighter) fibers. Although all the type
2 fibers show large diameters, both large and small type 1 fibers are
observed, which produces a smaller mean diameter (“type 1 relative
hypotrophy”). c and d, Patient 2 at 14 years of age, right deltoid;
nicotinamide adenine dinucleotide–tetrazolium reductase (NADH-TR)
(c) and succinate dehydrogenase (d). Multiple focal areas lacking ox-
idative activity are present in most type 1 (darker) and type 2 fibers.
As shown here in two different biopsy specimens, there was no sig-
nificant increase in endomysial connective tissue. e–g, Longitudinal
electron micrograph sections from patients 8 (e, f) and 16 (g); left
quadriceps and left deltoid at 23 and 5 years of age, respectively. e
and f, Mild, early-stage minicore lesions; the sarcomeres appear out
of register, Z-line streaming is limited to one sarcomere in length and
3–4 myofibrils in width, and the longitudinal myofilament array is still
recognizable. g, Electron-dense material of Z-line origin, forming ir-
regular zones, with severe focal disorganization of the myofibrillar
structure. mm in a and b, 25 mm in c, 12.5 mm in d, and 2.5Barp 40
mm in e–g.
Linkage Analysis
Linkage analysis was performed using the LINKAGE
package, v. 5.2, under the assumptions of autosomal
recessive inheritance, an equal recombination frequency
for female and male subjects, a disease-gene frequency
of 0.0001, one liability class, and a penetrance of 0.95.
Two-point LOD scores were calculated for equal allele
frequencies, using the MLINK program. Results were
analyzed globally, family by family, and by groups of
families with the same phenotype. Haplotypes were con-
structed under the assumption of the minimum number
of recombinations.
SEPN1 Screening
All 13 SEPN1 exons and the selenocysteine insertion
sequence (SECIS) element, a secondary structure located
in the 3′ UTR of the transcript that allows selenocysteine
incorporation at a UGA codon (Moghadaszadeh et al.
2001), were screened for mutations by PCR-SSCP and
sequencing, using primers defined to amplify each exon
and exon/intron boundary (Moghadaszadeh et al. 2001).
We used the touchdown PCR method, with annealing
temperature decreasing from 70C to 60C in the first
10 cycles and being fixed at 60C in the final 20 cycles,
except for exon 3 and SECIS, for which the touchdown
60C–50C method was used. All PCRs were performed
using Platinum Taq polymerase (Gibco BRL/Life Tech-
nology), except for exon 1, which required the GC-rich
PCR system kit (Roche) for amplification. SSCP analyses
were performed on 10% acrylamide/bisacrylamide 37.5:
1 gels at 7C and 25C. PCR products were sequenced
on an ABI 3100 automated sequencer, using a BigDye
terminator kit (Applied Biosystems).
Exons 5, 7, 8, 10, and 11 were analyzed by denaturing
high-performance liquid chromatography (DHPLC) in
200 control chromosomes, as described elsewhere (Xiao
et al. 2001).
Results
Identification of a Potential Linkage to Chromosome
1p36
A genomewide screening was undertaken in 13 infor-
mative families with classical MmD. Linkage to the locus
on chromosome 19q13.1 that contains the RYR1 gene,
which was recently identified as responsible for the
moderate form of MmD with hand involvement, was
excluded in all the families. We found multiple mark-
ers potentially linked to the disease in this set of families,
but none of them gave a cumulative LOD score 13.
We then chose a combined positional/candidate-gene
approach. A possible relationship between classical MmD
and RSMD linked to chromosome 1p36 (RSMD1 locus)
was suspected on the basis of the following data: both
patients with RSMD and patients with classical MmD
share a predominantly axial myopathy, with particular
involvement of the respiratory function; four of the pa-
tients in our series, two of them siblings (F10), showed
spinal rigidity (Ferreiro et al. 2000); the endomysial fi-
brosis seen in the biopsy specimens of most of the pa-
tients with RSMD is very mild, with a general absence
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Table 1
Pairwise Cumulative LOD Scores for Linkage between the Disease
Phenotype and Markers on Chromosome 1p36 in the Eight Families
Showing Linkage
MARKER
LOD SCORE AT v p
.0 .01 .05 .1 .2 .3 .4
D1S3766 4.80 4.65 4.06 3.34 2.02 .97 .29
D1S3767 5.08 4.92 4.31 3.55 2.13 1.00 .28
D1S2885 4.34 4.21 3.69 3.05 1.84 .87 .25
D1S3768 3.96 3.84 3.37 2.78 1.71 .85 .27
D1S3769 5.55 5.39 4.74 3.95 2.45 1.22 .38
of necrosis and regeneration. Marker D1S234, which
had been included in the genome screening and is con-
tiguous to RSMD1, was analyzed family by family, be-
cause of the suspicion of genetic heterogeneity. We found
a potential linkage of this marker to the disease in 5 of
the 13 families, including family F10, with a cumulative
LOD score of 2.3 at recombination fraction (v) p 0.0.
We then analyzed contiguous microsatellite markers
defining the RSMD1 locus in all 27 informative families
in our series. We confirmed linkage to these markers in
a total of eight families, including seven with classical
MmD and one that showed some atypical findings. The
maximum cumulative LOD score in the linked subgroup
was 5.55 for D1S3769 at (table 1).vp 0.0
Linkage to 1p36 was excluded in the remaining 19
families, including 9 classical ones, all the families
presenting with arthrogryposis (2 families) or definite
ophthalmoplegia (2 families), and 6 of the 7 families
showing atypical features, such as congenital ptosis,
swallowing problems, or later onset of the disease.
Identification of SEPN1 Mutations
The coding sequence and the SECIS element (Mog-
hadaszadeh et al. 2001) of the SEPN1 gene were ana-
lyzed in the eight families showing linkage to 1p36 and
in 14 additional patients with classical, sporadic disease.
We identified nine different significant sequence altera-
tions in 17 patients belonging to 12 families. The geo-
graphic origin of these families is summarized in table
2, and their clinical phenotype is summarized in table
3. We failed to find any mutation in one of the eight
families with potential linkage to RSMD1.
The identified SEPN1 mutations are distributed
throughout the entire gene (table 2). Surprisingly, a ho-
mozygous mutation of the start codon (1ArG), which
changed the initiator methionine codon to a valine co-
don, was identified in three unrelated families of Italian,
Belgian, and German origin (F2, F3, and F4, respec-
tively), thus representing the most frequent mutation in
this series.
A homozygous insertion/duplication of 10 bp in exon
1, which was described elsewhere in North African pa-
tients with RSMD (Moghadaszadeh et al. 2001), was
identified in a German consanguineous family (F1). We
found a novel insertion of 1 bp in exon 5 (713-714insA)
in two unrelated French patients, one of them homo-
zygous and the other compound heterozygous. These
insertions cause a frameshift at Q8 and N238, respec-
tively, and thus, theoretically, should lead to a truncated
protein.
We identified six missense mutations in 11 patients.
Two of them (1397GrA and 878ArG), which were de-
scribed elsewhere in homozygous patients with RSMD
(Moghadaszadeh et al. 2001), were found in the hetero-
zygous state in four families with MmD (three French and
one German); 1397GrA changes arginine 466 to gluta-
mine, and 878ArG leads to replacement of histidine 293
by arginine. The remaining four were novel missense mu-
tations. Homozygous 943GrA, changing glycine codon
315 to a serine codon (G315S), was identified in exon 7
in two unrelated families from Belgium and the United
Kingdom that share identical RSMD1 haplotypes, thus
suggesting a founder effect. A German patient with spo-
radic disease presented the same mutation in a hetero-
zygous state. Interestingly, one homozygous mutation that
transformed the selenocysteine codon in exon 10 into a
glycine codon (U462G) was found in a Portuguese family.
Two other heterozygous missense mutations, 1019ArT
(N340I) and 1358GrC (W453S), were identified in two
French families; one mutation changed an asparagine to
an isoleucine, and the other changed a tryptophan to a
serine. All these missense mutations changed evolution-
arily conserved amino acids and were absent from 200
control chromosomes.
Segregation analysis showed that all the sequence
changes were transmitted by the heterozygous parents;
no de novo mutation was found.
Clinical Features
All the patients with MmD and SEPN1 mutations
showed quite homogeneous clinical features, consistent
with the severe end of the classical MmD spectrum and
marked by congenital and severe axial weakness with
early scoliosis and respiratory failure, which contrasted
with a fairly well-preserved strength of limb muscles.
In all 17 patients (9 male and 8 female), the first signs
of the disease were evident during the first year of life;
in 8 of them, hypotonia, scoliosis, and/or respiratory
failure were noticed at birth. Poor or no head control,
revealing a predominantly axial hypotonia and weak-
ness, was invariably an early sign. In contrast, the re-
maining milestones of motor development were only
moderately delayed; 13 patients were able to walk
independently at a normal age, and all acquired am-
bulation at the mean age of 17.7 mo. Because of this
relatively good walking ability, a myopathy was not sus-
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Table 2
SEPN1 Mutations in Patients with MmD
Family
No. of
Affected
Children Origin
Known
Consanguinity Exon
Nucleotide
Change Homozygous
Amino Acid
Changea
F1 1 Germany Yes 1 22dup10bpb Yes Frameshift at Q8
F2 2 Italy No 1 1ArG Yes Unknown
F3 1 Belgium No 1 1ArG Yes Unknown
F4 1 Germany Yes 1 1ArG Yes Unknown
F5 1 France No 5 713-714insA Yes Frameshift at N238
F6 1 France No 5 713-714insA No Frameshift at N238
11 1397GrA No R466Q
F7 2 Belgium No 7 943GrA Yes G315S
F8 2 United Kingdom No 7 943GrA Yes G315S
F9 1 Germany No 7 943GrA No G315S
11 1397GrA No R466Q
F10 2 France No 7 878ArG No H293R
8 1019ArT No N340I
F11 2 Portugal No 10 1384TrG Yes U462G
F12 1 France No 10 1358GrC No W453S
11 1397GrA No R466Q
a U p selenocysteine.
b The insertion/duplication found in F1 (22dup10bp), causing a frameshift at Q8, has been reported elsewhere as G7fs
in North African patients with RSMD (Moghadaszadeh et al. 2001).
pected in some patients until their late teens. Neverthe-
less, most patients have never been able to run and have
always had difficulties climbing stairs or walking long
distances, showing a certain degree of fatigability.
Although a variable degree of weakness and slender-
ness was present in most muscles, they were always more
marked in axial muscle groups. Muscle weakness was
extreme for neck flexion (0 to 2, according to the Med-
ical Research Council scale) and rotation; sternoclei-
domastoideus bulk was often particularly reduced. Cer-
vical and dorsal spinal extensors (1 to 2), trunk flexors
(1 to 2), and scalene muscles and intercostal muscles
were also severely affected. In contrast, limb muscles
were relatively preserved, globally scoring between 3
and 4. Quadriceps power was often particularly good.
Amyotrophy of the inner thigh led to a particular leg
aspect that is shown in figure 2. Most patients had a
nasal, high-pitched voice and a variable degree of fa-
cial weakness.
No limb contractures were observed in any patient
who was !3 years of age. Indeed, most patients showed
a moderate degree of distal hyperextensibility, which es-
pecially affected the metacarpal-phalangeal joints. In
contrast, retractions of the pectoralis and intercostal
muscles and of the costoiliac space were early, common,
and severe findings, leading to a poorly developed, flat
thoracic cage. Except in patient 16, who presented with
congenital cervical scoliosis, cervical contractures were
never early findings. In fact, the head dropped forward
in some patients—either permanently or when walking—
throughout infancy and childhood. In most patients,
neck extensor retractions and a variable degree of spinal
rigidity developed later; in some instances (seven pa-
tients) this was noticed by the clinician referring the pa-
tient, whereas in other patients (six) this information
could be retrospectively retrieved from the family. Spinal
rigidity was never detected in four patients. Hip flexor
contractures were common, and, in one instance (patient
4), they resulted in a hyperlordosis that preceded the
development of scoliosis by several years. Approxi-
mately half of the patients also developed late, mild-to-
moderate knee and elbow retractions.
The most striking findings in these patients were early
and severe respiratory failure and scoliosis. Scoliosis,
present from a mean age of 8.5 years, was generally
cervicodorsal, associated with dorsal lordosis and a lat-
eral trunk deviation, and progressive, even in those pa-
tients who showed stable weakness or improving motor
performance. In spite of early intensive orthopedic treat-
ment, an extensive arthrodesis was required in nine pa-
tients, and the procedure resulted in stabilization of sco-
liosis and improvement of orthopedic and respiratory
symptoms. Restrictive respiratory insufficiency (vital ca-
pacity 13%–47% of expected values) was the abnor-
mality that led to referral of patients 15 and 17, and it
required early respiratory assistance in all but the two
youngest patients, who are now aged 10 and 5 years.
Six patients underwent tracheotomy. The degree of
hypercapnic respiratory insufficiency was always dis-
proportionate to the severity of scoliosis and to the de-
gree of general weakness; all the patients requiring ven-
tilation were still ambulatory. The major determinants
of this respiratory involvement were the involvement
of accessory respiratory muscles, the presence of dia-
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Figure 2 Clinical features. a, Patient 12 at age 5.5 years. Slender
neck with absent sternocleidomastoideus bulk, flat thorax, and mod-
erate deltoid atrophy are present from early stages of the disease, as
is an unusual appearance of the lower limbs, characterized by amy-
otrophic inner thighs, straight calves, and flat feet. Scoliosis also fol-
lows a particular pattern, with associated dorsal lordosis (“hollow
back”) and a lateral trunk deviation and frequently requires an ex-
tensive arthrodesis (b and c). b, Patient 7 at age 15 years, immediately
before surgical correction. c, Stabilization of the spinal deformity in
patient 6 at age 17 years, 4 years after arthrodesis.
phragm dysfunction, and the severity of thorax defor-
mities. In each case, the value of vital capacity measured
in dorsal decubitus was significantly reduced, by 14%–
46% of the value obtained when the same patient was
sitting or standing, which clearly indicates diaphrag-
matic involvement. Diaphragm paralysis was radiolog-
ically demonstrated in five instances (patients 5, 10, 11,
15, and 17). Remarkably, episodes of nocturnal desat-
uration and a high frequency of short apneic periods
were detected in 10 of the 13 patients in whom poly-
somnographic studies were performed, even at early
stages of the disease with fairly well-preserved vital ca-
pacity (e.g., patient 9, with a vital capacity of 47%).
Failure to thrive, short stature, and low body weight
were present in all but one patient and constituted the
first referral sign in patients 7, 10, and 11. In early adult-
hood, the mean body weight was 36.25 kg, and the mean
height was 1.54 m. Heart function tests, such as echo-
cardiography, electrocardiography, and/or Holter record-
ings were routinely performed, and they disclosed no,
or only minor, cardiac abnormalities. Intelligence was
always normal. Serum creatine kinase levels were, in
general, normal and were never more than four times
as high as the upper limit of the normal range.
Muscle weakness remained stable in 13 (76%) patients
and was slowly progressive in 4. Most patients remain
able to walk, at least for short distances (as far as 1.5
km); eight of them lead entirely independent, active lives
in adulthood. An exception is patient 5, who was ini-
tially considered to have an atypical, particularly severe
form of MmD, because of early and marked ankle re-
tractions (which required surgical correction), major hy-
perlordosis from the age of 1 year, absence of scoliosis
before the age of 10 years, steady progression of limb
weakness, and obesity. He lost the ability to walk at 8
years of age and is capable of only partial antigravity
movements of hands and forearms at age 15 years. He
has a facial diplegia and requires permanent ventilation
through a tracheotomy, his vital capacity being reduced
to 6% in the lying position.
The severity of the disease was defined by its effects
on the respiratory function. One patient (patient 2) had
severe respiratory insufficiency and died at 29 years of
age. Symptoms of the remaining patients are well con-
trolled, after scoliosis stabilization, with intermittent,
positive-pressure, mainly nocturnal ventilation.
Morphological Findings and Reevaluation
In a specific search for the presence of dystrophic le-
sions, we performed a second analysis of the muscle
biopsy specimens from eight patients with MmD pre-
senting different mutations. The samples originated from
the deltoid (five samples), quadriceps (one sample), or
unspecified muscles (two samples). Ages at the time of
the diagnostic biopsy were 5–20 years (mean 10.3 years).
In patients 1, 4, and 12–15, a previous muscle biopsy
had been considered normal or nondiagnostic.
Increased variability of fiber size, predominance and
relative hypotrophy of type 1 fiber, and a variable
percentage of centrally located nuclei (6% of the
fibers) were consistent findings. Typical oxidative-
negative lesions affected both fiber types. Only a mild
degree of endomysial fibrosis was present in the various
samples, and it was entirely equivalent to that observed
in any other congenital myopathy. No necrotic fibers
were observed; in contrast, we found some sparse, iso-
lated basophilic fibers, probably representing a regen-
eration process, in the samples from patients 7, 13, and
16 (maximum three regenerating fibers per transverse
section of biopsy specimen).
In view of the genetic and clinical overlap, we ana-
lyzed, by light and electron microscopy, the muscle bi-
opsy specimens from three patients who were previously
diagnosed as having typical RSMD and who had known
mutations in SEPN1 (patients RSMD1–RSMD3). Our
objective was to reassess the morphological signs of con-
genital muscular dystrophy (CMD) and to look for the
presence of core lesions. Analysis of these specimens, all
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Figure 3 Histochemical and ultrastructural analysis of deltoid muscle biopsies taken from patients with RSMD at the ages of 11 (RSMD1
and RSMD2) and 14 years (RSMD3). a–f, Transverse cryostat sections; g–i, longitudinal electron micrograph sections. All samples show fiber
size variability (a–c, HE) and focal oxidative-negative areas (arrows; d–f, NADH-TR) corresponding, at the ultrastructural level, to short regions
of Z-line streaming and sarcomere disarray (g–i). The myopathological pattern in RSMD1 is equivalent to that in patients with typical MmD;
absence of necrosis, regeneration, and endomysial fibrosis coexists with the presence of short core lesions in most fibers. In contrast, in RSMD3,
there is a predominance of dystrophic features, such as regenerative fibers (asterisks) and marked increase of endomysial connective tissue, while
small zones of Z-line streaming were present in less than half of the fibers. Sample RSMD2 presented an intermediate pattern, with some rare
regenerative fibers (asterisk), no significant fibrosis, and multiple minicores in approximately two-thirds of the fibers. Bar p 40 mm in a–c, 25
mm in d–f, and 2.5 mm in g–i.
taken from the deltoid muscle at similar ages, showed
an unexpectedly wide myopathological spectrum (fig. 3).
Patients RSMD1 and RSMD3 (of Turkish and Iranian
origin, respectively) share the same homozygous muta-
tion (G273R) and have been reported elsewhere (Mog-
hadaszadeh et al. 2001). The biopsy from patient RSMD1
is consistent with typical MmD, because of the presence
of multiple minicores in most type 1 and type 2 fibers
in the absence of any dystrophic feature. In contrast, the
sample from patient RSMD3 shows a clearly dystrophic
pattern, with severe endomysial fibrosis, some regener-
ating fibers, and occasional small zones of Z-line stream-
ing. French patient RSMD2 shows a homozygous in-
sertion, 713-174insA, that was also found in some
patients with MmD. Her biopsy specimen reveals an
intermediate pattern, with abundant minicores, mild en-
domysial fibrosis, and sparse regenerating fibers.
Discussion
Congenital myopathies, such as MmD, are early-onset
hereditary muscle disorders defined, on morphological
grounds, by particular changes in the architecture of
muscle fibers (Fardeau and Tome´ 1994) that occur in
the absence of necrosis, regeneration, or significant en-
domysial fibrosis. These last myopathological features
are generally referred to as “dystrophic signs,” and,
when they coexist with infantile-onset hypotonia and
weakness, they are considered typical of another het-
erogeneous group of congenital muscle disorders, the
CMDs (Dubowitz 1995). On the other hand, the pres-
ence of a variable degree of spinal rigidity is known to
be a nonspecific manifestation of multiple myopathies
(Merlini et al. 1989; Topaloglu et al. 1994; Fadic et al.
1997; Kubo et al. 1998). The term “rigid spine syn-
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drome” (RSS) was first proposed by Dubowitz to de-
scribe the condition in a subset of patients affected by
myopathy with early spinal contractures as a prominent
feature (Dubowitz 1973). He referred to it as a nonpro-
gressive “muscle syndrome in search of a name” and
stressed the difficulties of classifying it, which made it,
for some time, a myopathy of uncertain nosological po-
sition (Poewe et al. 1985). Only recently, a subgroup of
patients presenting early-onset RSS, together with axial
and proximal muscle weakness and severe respiratory
failure, have been classified as having a form of CMD,
RSMD (Echenne et al. 1983; Banker 1994; Muntoni and
Guicheney 2002). A group of these families is linked to
the RSMD1 locus, located on chromosome 1p36 (Mog-
hadaszadeh et al. 1998); the gene causing the disease in
these patients has recently been identified as SEPN1,
which codes for selenoprotein N (Moghadaszadeh et al.
2001).
After independent analysis of a series of patients with
MmD, through a combined positional/candidate-gene
approach, we found nine SEPN1 mutations in 17 pa-
tients from 12 families. All of the patients showed an
axial myopathy, with scoliosis and respiratory failure
in all but the two youngest; a varying degree of spinal
rigidity was a frequent, but not universal, feature. These
findings provide definitive evidence that SEPN1 muta-
tions are responsible for a proportion of cases of the
classical form of MmD. Some of our patients have
mutations previously found in patients with RSMD.
In addition, after morphological reevaluation, we
found typical minicore lesions in two of three patients
with RSMD. Taken together with the clinical similarity,
these data support the idea that RSMD and the most
severe form of classical MmD are not only allelic dis-
orders but the same entity.
Whether this entity must be considered a CMD or
a congenital myopathy is, however, difficult to estab-
lish. In most patients with RSMD, both in the literature
and in our series, no signs of necrosis or regeneration
were observed; and endomysial fibrosis, considered the
hallmark of CMD, was absent or mild (Muntoni and
Guicheney 2002). Furthermore, minicores have been oc-
casionally described in RSS (Serratrice et al. 1984; Ben
Hamida et al. 1987), although the lack of details con-
cerning oxidative staining and electron microscopy in
most of the reported cases make the frequency of core
lesions difficult to establish. Because minicores are non-
specific lesions verifiable only after extensive histochem-
ical and ultrastructural analysis, which are not routinely
performed in patients with CMD, their frequency may
have been underestimated. We analyzed the biopsy spec-
imens of the three patients with RSMD available for
study in our laboratory and found typical minicore le-
sions in two of them and small regions of Z-line stream-
ing in the third. Taken together, these data suggest that
this entity constitutes a congenital myopathy with min-
icores, rather than a form of CMD. Nevertheless, the
presence of some rare regenerating fibers in the mor-
phological reanalysis of some patients with MmD, as
well as the finding of a clearly dystrophic pattern in one
of the patients with RSMD and SEPN1 mutations, is
not consistent with the classical criteria of congenital
myopathies. The patient’s age at the time of the muscle
biopsy and the type of muscle sampled might play a
role in this morphological variability, because axial
muscles tend to be more severely affected than those of
the limbs. However, these factors cannot explain the
differences we found in comparable deltoid samples
taken at similar ages, which suggests that the structural
changes in muscle probably do not represent a primary
developmental abnormality. The nosological situation
of this group of patients thus needs further discussion,
but it is now clear that SEPN1 mutations are associated
with a wide morphological spectrum. We propose that
this entity could be tentatively referred to as SEPN-
related myopathy.
In contrast with the morphological variability, the
clinical features are remarkably homogeneous in all
patients. The hallmark of their phenotype is the pre-
dominantly axial muscle impairment, leading to life-
threatening respiratory involvement and scoliosis,
which, if adequately treated, tend to remain stable after
the growth spurt. A variable degree of spinal rigidity is
evident in many, but not all, patients. The fact that limb-
muscle strength remains relatively preserved—and that
most patients are ambulatory—deferred the diagnosis
of myopathy in some patients until they were in their
late teens, when arthrodesis or respiratory assistance
became necessary. In some patients, failure to thrive and
diffuse amyotrophy, disproportional to weakness, were
the referral signs. In fact, most patients in our series
had a short stature and, as reported elsewhere (Seay et
al. 1977; Goto et al. 1979, 1981; Mussini et al. 1982;
Vogel et al. 1982; van Munster et al. 1986), hardly any
subcutaneous fat.
The coding and genomic sequences of SEPN1
(GenBank accession numbers AJ306399 and AJ306398)
have been recently established. The SEPN1 gene con-
tains 13 exons and encodes a 590–amino acid protein
whose function and subcellular localization are un-
known. On the basis of the protein structure and anal-
ogies with other selenoproteins with known function,
an enzymatic activity has been hypothesized (Lescure et
al. 1999; Fagegaltier et al. 2000). With the exception
of selenophosphate synthetase-2, the selenoproteins
whose function has been identified so far are catalysts in
redox processes (by using thiols as electron donors) or
in thyroid hormone processing (Behne and Kyriakop-
oulos 2001). In humans, selenium deficiency has been
related to the cardiomyopathy known as “Keshan” dis-
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ease (Xu et al. 1997) and to a parenteral nutrition–
associated myopathy (Brown et al. 1986; Osaki et al.
1998). In animals, selenium-deficiency diseases include
livestock growth depression (“ill-thrift”) and white-
muscle disease, a selenium-responsive myopathy of
heart and skeletal muscle, principally affecting lambs
and calves (Rayman 2000). Although there is not nec-
essarily a strict correlation between selenium deficiency
and SEPN abnormalities, some of these entities provide
interesting data that, together with the morphological
lesions present in SEPN-related myopathy, could pro-
vide some clues about the physiopathological mecha-
nisms potentially implicated in this disease.
One of the primary lesions in white-muscle disease is
calcification of skeletal and cardiac muscle (Schubert et
al. 1961), and it has been demonstrated that the sarco-
plasmic reticulum membranes from muscle of affected
animals have lost their ability to sequester calcium
(Tripp et al. 1993). It is thus interesting to note that the
only genetic defect related so far to a minicore myopathy
consists of mutations of RYR1, a gene encoding a cal-
cium-release channel of the skeletal muscle sarcoplasmic
reticulum (Ferreiro et al. 2002; Jungbluth et al. 2002).
On the other hand, SEPN contains a motif that strongly
resembles calcium-binding domains found in calcium-
binding proteins, such as calmodulin (Moghadaszadeh
et al. 2001). Furthermore, mitochondria have been sug-
gested to respond to spatially confined Ca2 release from
sarcoendoplasmic reticulum Ca2 stores (Rizzuto et al.
1998; Pacher et al. 2002). It is thus attractive to spec-
ulate that the focal areas of mitochondria depletion ob-
served in both RYR1- and SEPN1-related myopathies
might reflect abnormalities in the calcium-mediated lo-
calized interaction between the sarcoplasmic reticulum
and the mitochondria. Further studies are necessary to
confirm this hypothesis.
In conclusion, mutations in SEPN1 account for a con-
siderable proportion of patients with predominantly ax-
ial myopathy, severe scoliosis, and early respiratory fail-
ure, whose morphological features range from typical
MmD to typical CMD but almost always include mini-
core lesions. These findings open the way to a concep-
tual change in the nosological classification of early-
onset myopathies, of which SEPN-related myopathy
probably represents a much larger proportion than was
expected.
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